Apr. 28 at 11:15 AM
$XYL Xylem beats by
$0.04, reports revs in-line; guides FY26 EPS in-line, revs in-line
Reports Q1 (Mar) earnings of
$1.12 per share, excluding non-recurring items,
$0.04 better than the FactSet Consensus of
$1.08; revenues rose 2.7% year/year to
$2.13 bln vs the
$2.11 bln FactSet Consensus.
Orders of
$2.2 billion, up 3% on a reported basis and flat organically.
Co issues in-line guidance for FY26, sees EPS of
$5.35-
$5.60, excluding non-recurring items, vs.
$5.48 FactSet Consensus; sees FY26 revs of
$9.2-
$9.3 bln vs.
$9.19 bln FactSet Consensus. Full-year free cash flow margin is still expected to be approximately 10.2 to 11.0 percent.
